Procter & Gamble has initiated a strategic collaboration with a tech startup to integrate generative AI into its oral care R&D pipeline, aiming to accelerate innovation in its 220-year-old Crest toothpaste line. The move marks a pivotal shift in the company’s approach to product formulation and consumer insights.
- Procter & Gamble (PG) partnered with NovaForm AI to integrate generative AI into Crest toothpaste R&D
- Target: reduce product development time from 18 months to 11 months (40% improvement)
- PG’s 2027 AI investment: $2.3 billion across digital transformation initiatives
- Pilot results show 28% improvement in user-reported comfort satisfaction for Crest Sensitivity Relief
- PG stock rose 1.7% post-announcement; ^VIX closed at 14.8, indicating stable market sentiment
- Two new Crest products expected by late 2026, with potential expansion to Gillette and Olay
Procter & Gamble (PG) has announced a formal partnership with NovaForm AI, a private technology firm specializing in generative modeling for consumer goods, to embed artificial intelligence into its product development workflow for the Crest brand. The collaboration, effective Q2 2026, targets a 40% reduction in the time required to bring new oral care formulations to market, from an average of 18 months to approximately 11 months. This initiative is part of PG’s broader digital transformation strategy, which includes a $2.3 billion investment in AI infrastructure through 2027. The integration focuses on using AI to simulate consumer responses to ingredient combinations, predict efficacy outcomes, and optimize packaging designs based on real-time social sentiment analysis. NovaForm AI’s platform leverages multimodal deep learning models trained on over 10 million consumer reviews, clinical studies, and regulatory filings. Early pilot results from the Crest Sensitivity Relief line showed a 28% improvement in user-reported comfort satisfaction within three months of algorithm-guided reformulation. Market indicators suggest investor interest in this shift. PG’s stock (PG) rose 1.7% following the announcement, while the broader consumer staples sector (XLP) posted a modest 0.4% gain. The S&P 500 (SPX) and CBOE Volatility Index (^VIX) remained stable, with the latter closing at 14.8—indicating low market uncertainty despite the tech-heavy initiative. Analysts note the move could enhance PG’s agility in a competitive landscape where brands like Colgate-Palmolive (CL) are also investing in AI-driven R&D. The project is expected to yield at least two new product launches under the Crest brand by late 2026, with initial focus on personalized oral care solutions tailored to demographic and behavioral data. The success of this pilot could extend to other PG brands, including Gillette and Olay, as the company expands its AI adoption across product categories.